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An immunonephelometric method developed for measurement of retinol-binding protein (RBP) in serum and urine can detect it in concentrations of about 30 g/L, which is in the lower limit of its normal concentration in urine (range 0-0.56 mg/L; mean ± SD 0.19 ± 0.15; n = 44). Urinary RBP was increased (range 0.93-29.5 mg/L) in all of 25 urine specimens from 13 subjects being treated with aminoglycoside (tobramycin). Urinary excretion of RBP was correlated (r = 0.83) with the excretion of j32-microglobulin. The within-assay and day-to-day precision (CV) was determined over the detection range of 0.03-8 mg/L. Within these limits the corresponding CVs varied from 4 to 27% and from 8 to 30%, respectively. The method had fairly good precision within the optimal measuring range of approximately 0.4 to 4.5 mg/L for both urine and 20-fold diluted serum samples. For various RBP concentrations our analytical recovery was 89-114% of added RBP. Results by this method correlated well (r = 0.96, n = 24) with those by a radial immunodiffusion method. The normal mean concentrations of RBP in plasma are reportedly on the order of 40-50 mgIL, and correlate significantly with that of plasma retinol (3, 7). Under normal circumstances about 85% of RBP is believed to circulate in the form of a protein-ligand complex (holoprotein) (7). Here we describe a relatively simple and fast immunonephelometric method for analyzing RBP in serum or plasma and in low concentrations in urine samples. We used this method to determine urinary RBP concentrations in normal subjects and, because aminoglycosides are nephrotoxic, in patients who were receiving tobramycin (8) .
Materials and Methods
Materials
Serum
and urine samples.
Serum and urine specimens were obtained from apparently healthy laboratory workers, ages 20 to 40 years. Serum and 24-h urine collections were obtained from 13 hospitalized patients who were receiving therapy with aminoglycoside (tobramycin). The patients had normal values for creatinine clearance and no increased systemic production of 132-microglobulin or lysozyme. The samples were stored at -70 or -20 #{176}C before assay of urinary and serum creatinine (9) , RBP in serum and urine, and serum retinol. /32-Microglobulin in serum and urine was determined by Phadebas 13.4-micro Test RIA (Pharmacia, Uppsala, Sweden) according to the standards and recommendations of the manufacturer.
Our laboratory reference values for 32-microglobulin in apparently healthy individuals are <400 p.gtL in urine, and 1.0-2.5 mg/L in serum.
RBP antiserum.
Rabbit antihuman RBP-antiserum (titre as antigen binding capacity 45 pg/mL) was obtained from DAKO, Copenhagen, Denmark. The specificity of the antiserum was tested by immunoelectrophoresis on agarose gel in V 10.0. glycol-6000 assay buffer, and filtered through a 0.45-sm (av. pore size) filter. The buffer alone, for blank determinations, was also filtered before use. We pipetted 100 L of standard or sample, followed by 200 L of diluted antiserum (or buffer for blank determination), into cuvettes of the laser nephelometer (Behring, Hoechst AG, Frankfurt, F.R.G.) and incubated them for exactly 1 h at room temperature before the light-scatter signals (in volts) were measured.
Blank readings were subtracted from the total readings, and the specific scattering was plotted vs the respective standard concentration on log graph paper. The sample concentrations were read from the log curve, and the results, in milligrams per liter, were multiplied by 20 (the dilution factor) for serum analyses.
RBP was also measured by immunodiffusion (LC-Partigen-RBP; Behringwerke AG), according to the manufacturer's recommendations; the resulting precipitin rings were measured after an incubation of 72 h. The mean withinassay and day-to-day CVs, determined over the measuring range of 2 to 36 mg/L, were 6 and 8%, respectively. When the urine RBP exceeded the lower detection limit of the immunodiffusion plates, the samples were applied unconcentrated. Otherwise, they were concentrated with Minicon-B Clinical Sample Concentrators (Amicon Corp., Danvers, MA 01923). The results for concentrated urine samples were corrected for the percentage of recovery.
Retinol measurements.
Serum retinol was determined by the methods of De Leenheer et al. (11, 12) . These methods were modified and tested in our laboratory to give reproducibility and accuracy equal to that reported in those studies. Figure 1 shows results of experiments on optimization of the immunonephelometric RBP assay. A PEG-6000 concentration of 70 g/L of assay buffer was optimal for analysis of RBP in urine samples. The standard curve covers a wide RBP concentration range, 0.03-16 mg/ L, that encompasses most RBP concentrations in urine. In only five urine samples of the 44 normal subjects studied was the RBP concentration less than the detection limit of the method (about 30 gIL). For serum RBP analysis, a lower concentration of polyethylene glycol-6000 (40 g/L) in the assay buffer was optimal.
Results
RBP assay method.
To assess the precision of the method, we assayed RBP in urine and serum within the range 0.09-4.6 mg/L. various RBP concentrations. The precision was poorer at lower RBP concentrations.
Thus the measuring range of approximately 0.4 to 4.5 mgIL is optimal, both for urine and 20-fold diluted serum samples. Analytical recovery of added RBP in urine is also shown in Table 1 . Table 2 shows in more detail the validation of urine RBP analysis by comparing the results from both of the methods.
RBP analyses
from serum samples. The radial immunodiffusion method is insufficiently sensitive for quantification of RBP in very low concentrations, as in normal urine samples (<0.56 mg/L), whereas with the immunonephelometric method we detected RBP in concentrations of 30 pg/L without preliminary concentration of the urine samples. The content of only five of the samples from 44 normal subjects fell below this limit of detectability.
In this study the measured mean urinary concentration for 44 normal subjects was somewhat higher than that reported by The specificity of the anti-RPB in the immunonephelometric method was validated by immunoelectrophoresis, which showed only a single precipitin arc in the a2-region. Similarly, in the Ouchterlony double-immunodiffusion technique, there was a single precipitin line. Dilution of a urine sample from a tubular proteinuric patient gave a response similar to the standard serum RBP in the assay. The normal serum proteins or other constituents of urine did not interfere in the assay.
In healthy subjects we calculated the mean molar saturation of RBP with retinol to be about 94%, supporting the view that almost all serum RBP exists as a ligand-protein complex (holoprotein). The concentration of circulating uncomplexed RBP can be assumed to be very low (7) . However, in comparison with the findings of Smith et al. (7), we found a better correlation between RBP and retinol, and about 10% greater molar saturation of RBP with retinol. We found the normal urinary concentration of RBP to be as low as 0.19 mg/L. However, RBP may constitute 10% or more of the total urinary protein in patients with proximal tubular reabsorption defects (3, 6). In our preliminary study of patients with aminoglycoside (tobramycin) therapy, we found the urinary excretion of RBP to be much increased (about 150-fold normal). This increase occurred concomi-tantly with an increase of urinary f32-microglobulin. 
